MP321 week 5 Flashcards

1
Q

functions of the skin (8)

A
  • a physical barrier to noxious agents and the entry of pathogens
  • an immunological barrier to the ingress of pathogenic organisms
  • assists retention of heat and regulation of temperature
  • retains moisture and maintains osmotic balance within the Body
  • a sensory organ- touch, social contact
  • excretion
  • vitamin D production
  • protection from UV in sunlight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

epidermis

A

outer most layer waterproof codified outer layer of keratin proteins and lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dermis

A

supporting region of the skin just below the epidermis
dermis-blood and lymph vessels
nerves and hair roots (hair follicle with sebaceous gland and muscle in Demis)
sweat glands- apocrine and eccrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

eccrine gland

A

in the dermis layer
secrete directly onto skin surface
thermoregulation, salt excretion, antibacterials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

apocrine gland

A

in the dermis layer
bud fatty secretions off into enclosed areas like hair follicles
especially found in axilla and public areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

layer of the epidermis

A

top nuclear squamous layer
granular layer
spindle layer
germinal layer- inner most

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

top nuclear squamous layer

A

Essentially dead as anuclear. Tough because of keratin, tightly joined. A tough waterproof barrier to the outside world and pathogens
Dead skin cells constantly shed off making dust, which is fed on by dust mites eat it and cause of allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

granular layer

A

Where cells have vesicles containing keratin fibre. Gets its name from its granular appearance under a microscope. Keratin strengthens them making them tough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

spindle layer

A

spindle layer cells form tight junctions anchored with adhesion proteins, cells glued into a sheet-like structure
differentiate and rise up further
this layer contains langerhans cells (APC or macrophages) specific to the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

germinal layer

A

is where the stem cells replicate and constantly divide and renew
then they migrate upwards based on a potential difference of a very small charge
also melanocytes (which produce pigment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

the pilosebaceous unit

A

Look in more detail of an apocrine gland
The hair follicle bases is in the dermis layer with the hair poking through the epidermis and out
Hair follicles are housed in the pilosebaceous unit.
2. The arrector muscle. When the arrector muscle contracts it pulls the base to an upright position, making the hair stand up-goosebumps
3. The pilosebaceous unit produces sebum- a sticky substance secreted on surface skin.
It is antibacterial and has low pH. It contains proteins and waterproofing lipids

Can change lipid content to modulate sweat evaporation to control thermoregulation
If there is obstruction of sebum secretion it may become infected, causing acne and other skin conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

meissner corpuscle

A

near the surface of the skin
responds to light pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pacinian corpuscle

A

deep in the skins layers
responds to deeper pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

merkel cells

A

middle skin layer
respond to sustained light pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

innervation of glabrous (non-hairy) skin

A

by fast conducting, low threshold mechanics-receptors (LTMRs) mediates sense of touch, vibration and pressure
specialised sensory nerves in the skin:

merkel cells
pacinian corpuscle
meissner corpuscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

examples of glabrous skin

A

non hairy
palms and soles of feet
rich in sensory nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

examples of hairy skin

A

major part of body surface
back, scalp etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

microenvironment

A

different skin regions vary greatly in their appearance and in the amounts of moisture and oiliness they typically carry
temperature and pH also

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

wound healing stages (4)

A
  • hemostasis
  • inflammation
  • proliferation
  • remodelling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

hemostasis in wound healing

A
  • fibrin is released by platelets
  • it is cross linked to make a plug to stop bleeding
  • helps prevent infections taking hold
  • langerhan cells patrol the local area and modulate response
  • release of histamine via mast cells causes vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

inflammation in wound healing

A
  • chemotactic factors are released into the bloodstream
  • monocytes move in by diapedesis
  • more neutrophils are attracted
  • mast cell activation
  • a cycle of inflammation
  • combats opportunistic infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

proliferation in wound healing

A
  • helps to form a scab on top of the wound
  • scab detached as skin grows underneath
  • endothelial cells proliferation promotes angiogenesis
  • fibroblast proliferation fills the underlying connective tissue and the skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

remodelling of the skin

A
  • skin repairs itself at the surface
  • wound edges come together to form a continuous barrier
  • healing continues underneath
  • myofibroblasts make pseudopods and migrate forward dragging cells behind them forward
  • gradually this enables the ends to come together
  • can take months to heal fully
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

factors directly affecting wound healing

A

Body site
Infection
Vascular supply
Oxygenation
Mechanical stress
Desiccation
Oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

factors indirectly affecting wound healing

A

Age and nutrition, medication, alcoholism, drug abuse, hygiene
Diabetes
Autoimmune diseases
Venous stasis
Predisposition to keloids (prominent scar tissue)
Some genetic skin diseases
Immunocompromised state (AIDS, cancer)
Obesity, immobility, vasculitis, neuropathy,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

tanning

A
  • UV light exposure induces double stranded breaks in DNA in keratinocytes
  • causes activation of a protein called p53(which is a tumour suppressor gene)
  • transcription of proopiomelaocortin (POMC)
  • POMC is cleaved into 2 species- B-endorphin acts as a local analgesic and A-melanocyte stimulating hormone (MSH) causes melanocytes to produce a pigment
  • melanosomes transfer pigment to keratinocytes
  • melanin absorbs UV light before it can reach DNA and damage it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

melanomas

A

Superficial spreading melanoma
Amelanotic melanoma
Nodular melanoma
Acral lentiginous melanoma
Uveal melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

skin microenvironment and the human microbiota

A
  • about 1 million bacteria per cm^2 of skin
  • thus healthy skin is home to many bacteria, viruses and fungi
  • together they make up a microbial bio community called the microbiota
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

the skin microbiota

A

Microbiota composition varies by area
Skin folds can affect microbiota
Oily skin can also influence this
Fungi tend to colonise creases and folds between the toes
Bacteria are found all over but particular species have their own favoured niches  Staphylococcus tends to favour enclosed/creases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Damage to the skin – Infections:
Possible contributions of the microbiota

A

Skin microbiota can cause skin infections
Genetic predisposition
can make skin more vulnerable
increased sensitivity to particular microbes
Change in microbial density/composition
more bacteria present mean it is easier to penetrate the skin
Metabolic diseases can alter the nutrients on the skin and the vascular supply
Change in the type of microbes?
Contextual pathogens
In a wound, normal microbes can become pathogenic
Drug treatments
Antibiotic or topical steroids can change growth conditions
Overgrowth or harmful bacteria?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

vesicles

A

fluid filled blisters the size of a pin head

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

bullae

A

fluid filled blister like eruptions around 1 cm in diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

acne vulgaris

A

Common in adolescence but can occur at any time
As a result of oily skin and the colonisation of blocked pilosebaceous unit

Causes: blockage of the pilosebaceous unit can allow infection (propionium bacterium acnes) and formation of pustules.
Signs and symptoms: If the infection is severe and the hair follicle ruptures, scarring can ensue.
Treatment: Depending on the severity, a variety of preparations are available. Topical benzoyl peroxide is one treatment, and tetracycline might be considered if symptoms are severe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

impetigo

A

Bacterial infection in the skin: Commonly affects face or extremities following injury. Bullae and or vesicles can form. Very contagious.
Causative factors: Usually caused by S. aureus or S. pyogenes. Commonly affects face or extremities in children following injury.
Signs and symptoms: Non-bullous type has pinhead pustules on red skin which erupt to give a yellow-brown crust after skin injury. (About 70% of cases)
Bullous type has larger blisters which release clear yellow liquid to leave a golden yellow crust (usually S. aureus on intact skin)
The golden crust is a key distinguishing symptom
Treatment: For most patients, topical treatment with bacitracin or mupirocin, although resistance in some areas. Also perhaps some care in playgroups etc. to avoid crowded conditions where it could spread.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

ecthyma

A

Causative factors: Often progresses from untreated impetigo (causing a deeper infection). Seen in homeless folk with poor hygiene, or soldiers in the tropics, especially if an affected area has been enclosed (as in footwear). Also occurs in immunocompromised individuals.
Although commonly associated with S. pyogenes and S. aureus, other bacterial species can also be associated with ecthyma.

Signs and symptoms: The infection penetrates to deeper layers of the skin causing the appearance of painful ulcers

Treatment: Warm compresses and antibiotics e.g. dicloxacillin

Treatment is difficult and can take a long time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

folliculitis

A

Causes: Infection of hair follicles by S. aureus usually. Often affects beard, armpits, back of the neck,
Signs and symptoms: Red pustules (furuncles) form and eventually rupture in a few days.
Treatment: Should be self-limiting and resolve naturally. Topical clindamycin and erythromycin on affected areas if necessary and anti-bacterial soap. Larger abscesses (carbuncles) may need to be surgically drained.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

erysipelas and cellulitis

A

Erysipelas (superficial infection) and cellulitis (deeper into the skin):
Causes: Involves lymphatic vessels. Erysipelas is often caused by S. pyogenes and cellulitis by S. aureus. Can travel through lymph to become a serious systemic condition (therefore than be life threatening)
Signs and symptoms: painful, warm, red swelling which forms a well defined plaque.
Treatment: Erysipelas: penicillin; cellulitis: dicloxacillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Necrotizing Fasciitis

A

Even deeper infection
Pathophysiology: Infection of subcutaneous tissue which can occur after surgery or trauma. Can be caused S. pyogenes alone but often involves a mixture of bacteria.
Signs and symptoms: Starts with warm red skin but lesion rapidly expands vertically and horizontally. The tissue becomes, dark, pustular then necrotic with gangrene.
Treatment: Fatal without prompt treatment. Surgical intervention is required along with parenteral antibiotics such as gentamycin and clindamycin
rapid expansion of the lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

dermatophytoses

A

fungal infection
Trychophyton rubrum is most common infectious fungus, and most fungal infections involve the genera Trichophyton, Microsporum and Epidermophyton

Forms of tinea (fungal skin infections):
Tinea pedis (athletes foot)
Tinea cruris (jock itch),
Tinea capitis (can cause cradle cap in babies)
Tinea corporis (also called ringworm)
Tinea unguium (onychomycosis) infection of nails

Topical treatment: with terbinafine, clotrimazole or econazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Tinea versicolor

A

Pathophysiology: Caused by the widespread yeast Malassezia furfur, more common in hot climates
Signs and symptoms: Results in lightened pigmentation of the skin in upper body and limbs. This can have psychological impact
Treatment: selenium sulfide shampoo or topical antifungal agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Candidiasis

A

Caused by the yeast Candida albicans part of the normal microbiota
Associated with immunosuppression
Can be associated with poor oral hygiene and dentures
Signs and symptoms: Inflammed and itchy membranes in moist mucous tissues such as mouth, vagina, armpits etc.

Treatment: topical antifungals, plus possibility of systemic antifungals such as ketoconazole, fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

herpes simplex 1

A

viral infection
Pathophysiology: 85% of population have antibodies to
HSV type 1. Virus resides in dorsal ganglia, until reactivated.
Signs and symptoms: Self limiting eruption around mucous membranes of mouth
Treatment: Acyclovir is favoured treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Herpes: Varicella zoster (chicken pox) and shingles:

A

viral infection
Pathophysiology: during chicken pox, the virus travels to sensory ganglia where it remains for life
Signs and symptoms: Pain and paresthesia in an affected dermatome
Treatment: Usually resolves with rest and analgesics, but acyclovir can be used, especially if virus is disseminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

warts

A

caused by human papilloma virus (HPV)
Warts are benign skin tumors caused by infection with the human papilloma virus (HPV)
Have dark necrotized blood vessels (dark specks) at the heart of the wart.
There are many strains of HPV. It is a very common virus, and most strains are benign.

Common (plane) wart (verruca vulgaris) affects the hands and face and knees and can spread.
Plantar wart- (verruca plantaris) grows into the skin of the foot and can cause pain.

Warts will often resolve spontaneously, but can be removed by some form of chemical, cryo or surgical ablation.

Some strains of genital warts can increase the risk of cervical cancer, but there is now a vaccine against this- Gardasil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Molluscum contaginosum:

A

Pathophysiology: Caused by the pox virus.
Transmitted by direct skin contact.

Signs and symptoms: Hyperplasia
Raised pink, pus filled lesions with a central depression.

Treatment: Often resolves spontaneously, but can linger in immunocompromised individuals. Children treated conservatively, but broadly similar treatment options as for warts with addition of curettage and cantharidin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

main causes of resistance in TB

A

Poor compliance

Inadequate treatment and diagnosis (“tools”)

Poor health care infrastructure

Lack of education and knowledge

Global location causes severe logistical issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

TB spread

A

inhalation of droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Why the resurgence of TB?

A

Complex chemotherapy used to treat the disease causes low compliance - old drugs!
Drug resistant strains have emerged (M/X/C DR-TB)
Strong epidemiological co-existence between HIV and TB as patients who are immuno-compromised easily catch TB (host defences can not fight bacteria in body)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Bacterial persistence in TB

A

After treatment a small percentage of bacteria may remain in a dormant state in macrophage
Complex mechanism between host and pathogen
These can become reactivated many years later
Patients shows no symptoms – carriers
2 - 23% lifetime risk of reactivation to secondary TB
Increased by 10% if immuno-suppressed (HIV or immuno-suppressants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

treatment of TB

A

2 phases- initial and continuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

initial phase

A

4 drugs given together daily - “triple therapy” Rifater®
Isoniazid (INH)
Rifampicin (RIF)
Pyrazanimide (PZA)
given with ethambutol

Duration of 2 months
Can be extended until sensitivity testing completed
(need to establish is bacteria will respond to drugs)
To reduce the bacterial population as rapidly as possible
Prevents resistance
Helps reduce chance of reactivation (PZA)
PZA only active during initial phase due to host immune response lowering pH in macrophages

52
Q

continuation phase

A

RIF and INH combination used
Rifinah® or Rimactazid®

Treatment continued for 4 months

Helps destroy remaining bacteria left from initial phase

Treatment extended for meningitis or resistant TB

But regime change is necessary in above cases

53
Q

DOT

A

Directly Observed Treatment
Necessary for patients who cannot comply with regime
Ensures the best chance of fighting the infection
Regime and doses need to be changed from non-DOT
Supervision given 3 times per week not daily

54
Q

mode of action of TB drugs

A

Main drugs used can be divided into two categories:
Bacteriostatic (inhibit growing bacteria)
Bactericidal (kill bacteria outright)
This distinction is relative and depends on environment
e.g. PZA is bactericidal against TB at low pH but bacteriostatic against growing bacteria
Bactericidal drugs are more effective at reducing bacterial populations
Bacteriostatics are still VERY important (eg ethambutol)

55
Q

first line TB drugs

A

Isoniazid (INH)
Rifampicin (RIF)
Pyrazinamide (PZA)
Ethambutol
Streptomycin
Superior efficacy with acceptable toxicity

56
Q

second line TB drugs

A

p-Amino Salicylic Acid
Fluoroquinolones
Capreomycin , kanamycin, amikacin
Ethionamide, Prothionamide
Cycloserine
Less efficacy and/or worse side effects

57
Q

Isoniazid (INH)

A

1952
Isonicotinic acid hydrazide
Targets the ketoenoyl-reductase enzyme InhA in cell wall mycolic acid biosynthesis
prodrug – activated to a binding complex with InhA

58
Q

Rifampicin (RIF)

A

1966
Prevents protein synthesis binding to DNA-dependent RNA polymerase b-subunit
Broad spectrum bactericidal activity
Helps sterilize “persistors” and active mycobacteria

59
Q

Pyrazinamide (PZA)

A

1952
Bacteriocidal against “persisting” slow growing mycbacteria
mode of action unclear but it is a prodrug requiring activation to the acid form pyrizinoic acid (POA)
Requires low pH macrophage environment (intracellular)

60
Q

resistance in TB

A

Occurs rapidly when single drug is used so combination therapy is the standard
mechanism via efflux or mutation at the target enzyme or the enzyme which activates prodrug to the active form
MDR-TB (INH and RIF) with/out 2nd line drugs
XDR-TB (INH, RIF, at least one the second line injectable aminoglycosides and any fluoroquinolone)
strains found where completely resistant

61
Q

future TB drugs

A

New drugs need to be more efficacious
Need to reduce the bacterial population faster
Need to combat MDRTB and be less prone to inducing resistance
Need to destroy persistent bacteria
Novel target to prevent cross resistance
Need to reduce duration of therapy and increase compliance
Need to be CHEAP (90% of patients can’t afford to buy them)
Compatible with RIF
Suitable for infants

62
Q

Treatment & classification of malaria

A

Tissue schizontocides- inhibit the growth of the pre-erythrocytic stages of the parasite in the liver. Hence they are sometimes called ‘causal prophylactics‘.
type I
- anti-folates
- inhibits dihydrofolate production
- sulfadioxine
- dapsone

type II
- anti-folate
- inhibits dihydrofolate reductase
- pyrimethamine
- proguanil

Hypnozoitocides - are only used to eradicate the dormant liver stage of vivax infections – primaquine (UK)
Disrupts the REDOX process in the pentose-phosphate pathway

Blood schizontocides- act rapidly and only on the erythrocytic stage of the infection. Some used prophylactically but mainly for treating ‘established’ malarial infection
Prevent hemozoin formation leading to cell death by binding to heme in the parasite

63
Q

Resistance in malaria

A

Resistance can develop and thus chemoprophylaxis guidelines vary with destination as does treatment for infection

Caused by mutation as active site or pro-drug activation in the chromosome

Preventing cellular uptake of the drug

Mainly due to Plasmodium falciparum

64
Q

Why is treatment difficult and long?

A

The disease causes many complex symptoms
M. tuberculosis has a very complex cell wall
Reactivation of “dormant” or “persistent” bacteria

65
Q

what is the most common symptom of an STI

A

the most common symptom is NO symptoms
however some other common symptoms include
- a genital rash
- a urethral discharge
- genital ulceration
- lymph node swelling in groin region
- a raised core body temperature

66
Q

why are STI rates higher in young people

A

important drivers include:
- cognitive
- behavioural
- biological

67
Q

cognitive development as factor in STI prevalence

A

younger adult tend to have less life experiences
- reduced reasoning or judgement capacity can negatively impact upon decision making processes
- tend to be more concrete thinkers
– focussed on immediate circumstances
– reduced ability to plan ahead

68
Q

behaviour as a factor in STI prevalence

A
  • less likely to use condoms
  • more likely to have multiple or overlapping partners
  • greater likelihood of substance use leading to riskier sexual practices
    -na significantly older partner predisposes to a power imbalance
    – makes sexual negotiation more difficult
    – higher risk of involuntary intercourse and unsafe sex
    – higher risk of exposure to STI
69
Q

biology as a factor in STI prevalence

A
  • younger female tend to be more biologically susceptible to becoming infected upon exposure
    – cervial ectopy (endometrial lining comes out and covers the front of the cervix- in vagina, bacteria can attach here more easily)
    – decreased local immunity in genital tract
    – a smaller nitrites and/ or lack of lubrication can lead to traumatic sex
  • in males increased STI susceptibility occurs in uncircumcised males regardless of age
    –phimosis
70
Q

sexual health inequalities

A

Disproportionately affects those experiencing poverty and social exclusion.
Most prevalent in:
- Asylum seekers and refugees
- Sex workers and their clients
- Homeless and young people in and/or leaving care.
- Men who have sex with men
- Some black & minority ethnic groups
- Young people.

71
Q

sensitivity of a test

A

sensitivity is the proportion of people with disease who will have a positive result

72
Q

specificity of a test

A

specificity is the proportion of people without the disease who will have a negative result

73
Q

what does sensitivity and specificity

A

High sensitivity is good for ‘ruling out’ a disease if a person tests negative
Mnemonic SnNout (high Sensitivity, Negative test = rule out)
High specificity is useful for ‘ruling in’ a disease if a person tests positive
Mnemonic SpPin (high Specificity, Positive test = rule in)
Positive predictive value (PPV) is proportion of people with a positive test who actually have the disease.
PPV = a/(a+b) = 0.62 or 62%
Negative predictive value (NPV) is proportion of people with a negative test who do not have the disease.
NPV = d/(c+d) = 0.98 or 98%
Diagnostic results need to be considered in parallel
with history and clinical assessment

74
Q

Chlamydia trachomatis

A

C. trachomatis is an obligate intracellular parasite
Small Gram-negative bacilli with no peptidoglycan layer in cell wall

Serovars D – K primarily associated with urogenital infections
Vertical transmission between mother & baby possible (conjunctivitis/pneumonia)

Serovars L1, L2, L2a & L3 associated with Lymphogranulosum venereum (LGV)

When pregnant will do tests so that they can be treated, can be passed from mother to baby during child birth and could also contribute to miscarriages and complications

C. trachomatis exists in two forms:
Elementary body (infective form)
Reticulate body (non-infectious form)

Chlamydia trachomatis elementary bodies infect columnar epithelial cells. The incubation period until clinical symptoms is around 1 – 3 weeks

75
Q

Clinical presentations of C. trachomatis

A

Majority are asymptomatic
50% of infected males
80% of infected females
Infection may cause a mucopurulent cervicitis in females and urethritis in males
Ascending infection can result in pelvic inflammatory disease (PID) in women
5-10% of PID women develop perihepatitis (Fitz-Hugh-Curtis syndrome)
Ascending infection can result in epididymitis in men.

PID- can c cause issues with reproduction

76
Q

Complications of untreated C. trachomatis

A

females

10-40% will develop PID
A significant proportion of cases are asymptomatic
Symptoms can include:
Vaginal discharge
Lower abdominal pain (dull, aching, crampy, bilateral, and constant) worsened by motion, exercise or intercourse
PID can result increase risk of infertility, ectopic pregnancy and chronic pelvic pain

males

Epididymitis which may reduce fertility or sterility
Prostatitis
Urethritis causing painful urination and possible kidney problems

77
Q

Diagnosis of Chlamydia

A

urethral swab
rectal swab
cervical swab
midstream urine

McCoy, Hep-2 or HeLa cell lines treated with cycloheximide (50 – 85% sensitivity; 100% specificity)

Nucleic acid amplification test (85 - 95% sensitivity; 99 - 100% specificity) - this is cheaper and faster

normally will just treat best guess before test results are back

78
Q

nucleic acid detection of bacteria in human sample

A
  • obtain human sample for testing
  • lyse bacterial cells to access ribosomal RNA (rRNA)
  • wash lysate over beads coated with DNA that will hybridise to rRNA of interest
  • pull down beads, isolating rRNA of interest
  • made double-stranded DNA (dsDNA) copy of rRNA
    -transcription mediated amplification of dsDNA into millions of RNA molecules
  • hybridise RNA molecules with fluorescent DNA probe, quantify fluorescence
79
Q

Treatment of Chlamydia-positive patients (prior to 2018)

A

Prefer a single dose treatment (compliance)
First line until 2018 was 1g single oral dose of azithromycin
However guidelines have changed in response to:
Mycoplasma genitalium co-infection in 3- 15% of cases (high incidence of macrolide resistance)
Concomitant rectal infections in women with urogenital infection, not related to anal intercourse (contribute to re-infection rates)

80
Q

Treatment of Chlamydia-positive patients

A

Uncomplicated urogenital infection:
Doxycycline 100mg bd for seven days (contraindicated in pregnancy)
Azithromycin 1g orally as a single dose, followed by 500mg once daily for another two days (3 days total)
Alternative options:
Erythromycin 500mg BD for 10 – 14 days
Ofloxacin 200mg BD (or 400mg OD) for 7 days (CI in pregnancy)
LGV - Doxycycline 100mg BD for 21 days
Abstain from all forms of sex during treatment
Contact tracing to minimise transmission

81
Q

Update: the promise of an effective chlamydia vaccine

A

Used a major outer membrane protein (CTH522) as the antigen
3 x IM injections of vaccine at 0, 1 and 4 months followed by 2 x intranasal boosters at 4.5 and 5 months
IM: 85mcg CTH522 liposomal adjuvant CAF01 (625 µg N,Nʹ-dimethyl-N,Nʹdioctadecylammonium [DDA] stabilised with 125 µg of the synthetic mycobacterial immunomodulator α,αʹtrehalose-6,6ʹ-dibehenate [TDB])
IN: 30mcg CTH522 (no adjuvant)
3 x IM followed by 2 x intranasal boosters
Vaginal antibody responses (IgA & IgG secretion) – humoral immunity
Interferon g production - cell mediated immunity

82
Q

Neisseria gonorrhoeae

A

N. gonorrhoeae is a Gram-negative intracellular, aerobic diplococcus
Female to male transmission is ~ 20% per vaginal intercourse episode (60 – 80% after 4 exposures)
Mucopurulent urethritis most common presentation (> 80%), 50% dysuria (some may be symptomless)
Male to female transmission is ~ 50 – 70% after vaginal intercourse
Includes vaginal discharge (≤ 50%), dysuria (10%), dyspareunia and mild lower abdominal pain (≤ 25%) (some may be symptomless)
Rectal infections ~ 40% female (similar in MSM)
Pharyngeal infections ~ 15% (oral sex – fellatio > cunnilingus)
Incubation period typically 1 – 14 days

83
Q

Neisseria gonorrhoeae

A

Deposited on mucous membranes during sexual activity (endocervix, urethral, anus, pharynx).
Attachment of bacteria using fimbrae to microvillus on non-ciliated columnar epithelial cells.
Bacteria gain cellular entry by parasite-directed endocytosis.
Bacteria transported to basement membrane and released by exocytosis where they multiply in the subepithelial tissue. This results in various inflammatory cells being recruited and various factors released
Cellular damage and inflammatory exudate accumulates in lumen.

84
Q

Gonorrhoea diagnosis and treatment

A

Primary diagnosis by NAAT
Sensitivity > 96%; specificity 99 – 100%)
Culture swabs for diagnosis and/or resistance profiling on Thayer-Martin plates
Sensitivity: 90 – 95% for males and 50 – 75% for females; specificity 100%)
Treatment of uncomplicated anogenital and pharyngeal infections:
1g ceftriaxone IM as single dose (if susceptibility unknown)
500mg ciprofloxacin as a single dose (if susceptibility known)
Test of cure in all patients recommended
Abstain from all forms of sex for 7 days

85
Q

Alternative regimes for gonorrhoea

A

Cefixime 400mg orally as a single dose plus azithromycin 2g orally
Only advisable if an intramuscular injection is contraindicated or refused by the patient. Resistance to cefixime is currently low in the UK.
Gentamicin 240mg intramuscularly as a single dose plus azithromycin 2g orally
Spectinomycin (unlicensed) 2g intramuscularly as a single dose plus azithromycin 2g orally
Spectinomycin is not recommended for pharyngeal infection because of poor efficacy.
Azithromycin 2g as a single oral dose – relapse risk high
The clinical efficacy of azithromycin does not always correlate with in vitro susceptibility testing and azithromycin resistance is high

86
Q

Anogenital warts (condyloma)

A

Caused by human papilloma viruses
Around 30 associated with anogenital infections
> 90% of anogenital warts caused by HPV 6 & 11
These types have low oncogenicity
Spread by skin to skin contact (penetrative sex not a prerequisite) or indirect e.g. sex toys. Present on:
Genitals
Groin region
Anus
Prevalence 30 – 50% population
Transmission rates M2F 55%; F2M 70% @ 3months
Incubation period – months to years

87
Q

Treatment for anogenital warts

A

Restricted to external visible warts
If less than 4cm2 skin surface involved then home treatment with topical podophyllotoxin
Four treatment cycles consist of BD application for 3 days followed by 4 days rest
30 – 70% response rate at 4 -6 weeks but recurrence common
Imiquimod for refractory cases (3 x week for up to 16 weeks)
Recurrence less common
Alternatives cryotherapy or electrocautery

88
Q

Anogenital herpes

A

Caused by HSV-1 or -2
Transmission by skin to skin contact (penetrative sex not required) or indirect e.g. sex toys
80% of people infected may experience no or such mild symptoms they remain undiagnosed
50% of population will have HSV-1 by age 30
3 – 10% of population will have HSV-2 (up to 25% of sexually active persons)
Incubation period may be 4 – 14 days or even longer

89
Q

Diagnosis & treatment for anogenital herpes

A

Primary infection may be characterised by flu-like symptoms and small blisters that burst to leave red open sores (up to 20 days duration)
Can include genitals, rectum, cervix, buttocks or thighs
Urinating can be painful
Diagnosis by sampling blister - PCR
Treatment with 400mg acyclovir TDS for 5 days
HSV-1 50% chance of at least one recurrence
HSV-2 80% chance of at least one recurrence
Frequency/severity of recurrence diminishes with time

90
Q

reasons for sterilising products

A

Medical or surgical procedures often breach the protective barriers of the host e.g. skin and mucosal surfaces or are topically applied to important body structures e.g. eyes, ears.

Critical that the pharmaceutical or surgical products being used are sterile to prevent the exposure of host tissue to potentially harmful microorganisms

91
Q

examples of sterile products

A

pharmaceuticals :
Parenteral injections & infusions, ophthalmic preparations, ear preparations, wound and bladder irrigations

surgical:
Wound dressings, artificial joints, cardiac pacemakers, surgical instruments, surgical gloves, hypodermic needles

92
Q

what is a sterile product

A

From an academic perspective the concept of sterility is absolute
complete absence of viable microorganisms from a product

From a Pharmacopoeial perspective the tests to establish sterility are often limited to the grounds of statistical probability due to limitations in the testing criteria available

93
Q

what does a sterilisation process achieve

A

Sterilisation refers to the process of removing or killing microorganisms from the product to render it sterile

A number of sterilisation methods are presently used:
Heat (steam & dry heat)
Radiation (e.g. gamma-rays or high energy electrons)
Gaseous (e.g. ethylene oxide or formaldehyde)
Filtration (with subsequent aseptic processing)

The exact method applied depends upon the physicochemical stability of the product to be sterilised

94
Q

Sterilisation process alone should not be relied upon for product quality

A

All the steps in the manufacturing process contribute to achieving sterility

Sterility also depends upon:
Microbial burdens of raw materials, equipment and facility
The operators
The use of validated sterilisation protocols
In-process control of the process and the production environment
Suitable storage conditions of the finished product to prevent recontamination

95
Q

Sterility does not sit in isolation of other product attributes

A

Parenteral products should:
be practically-free from particles (Pharmacopoeial limits)
be pyrogen free (Pharmacopoeial limits)
be physiological compatible in terms of pH, tonicity

Eye drops should be buffered near physiological pH of tears

These parameters still need to be considered as part of the overall development process

96
Q

Heat Sterilisation

A

Two methods are routinely used in sterilisation
Moist heat (denatures cell wall and cytoplasmic constituents (like proteins) and/or hydrolysis)- more effective
Dry heat (denatures by oxidation)

The destructive action of heat on viable microorganisms is most pronounced in the presence of moisture

The enhanced sensitivity of microorganisms to heat in the presence of moisture allows reduced operating temperatures and times to effect sterilisation

97
Q

Heat Sterilisation

A

Two methods are routinely used in sterilisation
Moist heat (denatures cell wall and cytoplasmic constituents (like proteins) and/or hydrolysis)- more effective
Dry heat (denatures by oxidation)

The destructive action of heat on viable microorganisms is most pronounced in the presence of moisture

The enhanced sensitivity of microorganisms to heat in the presence of moisture allows reduced operating temperatures and times to effect sterilisation

98
Q

Moist Heat Sterilisation

A

At normal atmospheric pressure steam would kill most but not all types of microorganism
E.g. bacterial spores remain viable even if they are heated for prolonged periods of time
Higher steam temperatures are used to ensure that all microorganisms are killed in a product
To obtain higher steam temperatures the water must be heated under pressure in an autoclave
Steam is merely water in the vapour (gas) phase
In order to transform water from the liquid to the vapour state energy must be added to the liquid

The energy input bringing about this physical change in phase can be sub-divided into two parts
Energy to raise the temperature of the mass of liquid water to its boiling point (4.2kJ/kg/°C)
Energy to transform the mass of liquid water at its boiling point to a vapour pressure (referred to as the latent heat of vaporisation = 2220kJ/kg)

The exact boiling point of water will be determined by the pressure of the atmosphere in which the water is heated (boiling point will increase with increasing pressure)

99
Q

steam

A

Steam is referred to as being saturated when it is
at a temperature corresponding to the liquid
boiling point appropriate to its pressure

The effectiveness of saturated steam under pressure at destroying microorganisms is intimately related to the physical properties of the steam under pressure that allow the steam to efficiently transfer heat to the product requiring sterilisation

When steam comes into contact with an object whose temperature is below the steam’s saturation temperature, the steam condenses into liquid water (at 121°C) on the object and transfers the latent heat of vaporisation (2220kJ/kg) to the object
Condensation causes a rapid contraction in volume (~785x ↓) and creates a localised region of low pressure that is filled by additional saturated steam

This property ensures the rapid penetration of the load by the steam
The process continues until the object reaches the temperature of the surrounding steam
Increased pressures are only used to elevate the temperature at which saturated steam is produced
The pressure itself has no antimicrobial action
Water quality used to produce saturated steam is also important otherwise contamination with chemical residues within water possible

If the temperature increases above the saturation-pressure boundary or if the pressure is reduced below the saturation temperature – pressure boundary then steam is referred to as being superheated

100
Q

superheated steam

A

Superheated steam behaves like an ideal gas and is not as lethal to microorganisms as saturated steam

101
Q

thermal stages within an autoclave

A

A- heating up phase
B- holding phase (where most microbial kill occurs)
C- cooling phase

102
Q

applications of moist heat sterilisation

A

Only products that can withstand the process temperatures and that are not susceptible to moisture damage can be sterilised by saturated steam
In practice three categories of product are sterilised
Aqueous products
Ophthalmic products
Large/small volume parenterals
These are normally contained in a non-porous container made of glass or thermostable plastic
Saturated steam does not have to come into direct contact with the product as the water content in the product will itself ensure inactivation of microorganisms as long as it is maintained at the sterilisation temperature

103
Q

non porous loads

A

Items such as surgical instruments, rubber closures for vials or items used in the production of sterile products e.g. Rubber tubing for transfer of sterile solutions or stainless steel mixing blades for mixers
Products usually wrapped into special containers that allow the penetration of saturated steam during the sterilisation process and prevent the ingress of microorganisms after the sterilisation process is complete
Porous loads
Porous materials that would be routinely sterilised include wound dressing and filters

104
Q

dry heat sterilisation

A

It is performed in a hot air oven
Poor heat transfer capacity of air lead to prolonged sterilisation cycles at higher temperatures than moist heat

Heat is provided by electrical heating elements placed around the internal insulated chamber wall
Fans within the oven ensure that air is evenly distributed throughout the oven to prevent temperature gradients within the oven

Heat is transferred to the products by conduction, convection and radiation

Variables such as the size and distribution of the load can influence heat transfer and performance of the oven

105
Q

applications of dry heat sterilisation

A

Used to sterilise a variety of thermostable products that are moisture sensitive
Ophthalmic ointments
Oil, wax and fat excipients that are used in the manufacture of sterile oily (depot) injections, implants or ointments
Powders used in the manufacture of sterile suspensions or powders
Depyrogenation of glassware
Temperatures > 220°C are routinely used to sterilise and destroy bacterial endotoxins on glassware
BP requires 3-log10 reduction in endotoxin(super potent)

106
Q

Radiation sterilisation

A

Only high energy g-rays and high energy electron beams are used to sterilise products

The introduction of radiation as a sterilising technique only became widespread after the development of the nuclear industry

Allowed the main isotope Co-60 to become available in sufficient quantities
Co-60 decays in a single step process to produce Ni-60

Co-60 -> Ni-60 + 2g-rays + b

The total energy of the g-rays and electron released from the Co-60 is 2.81MeV which is equivalent to 4.4 x 10-13J
The energies of the two g-rays allow them to penetrate through most products
Penetrate into a product with a density of water to a depth of 30cm
The BP recommends that a product receives a dose of 25kGy (2.5 x 104 J/kg) to achieve terminal sterilisation

gamma rays can damage API or container

107
Q

radiation continued

A

The energy from the g-rays is small compared to the energy input provided by moist or dry heat methods of sterilisation
However the energy delivered by an individual g-ray is highly localised as it penetrates through the product
The g-ray has sufficient energy to break covalent bonds found between atoms in organic macromolecules
Carbon-carbon bond is broken by an energy input of 5.77 x 10-19J
The alteration in the chemical composition of important macromolecules induced by the g-rays results in the death of the microorganism (May also denature product)

108
Q

Applications of radioactive sterilisation

A

Gamma-radiation has found widest use in the sterilisation of medical devices such as prosthetics, catheters, disposable plastic syringes and surgical clothing

It has also been used as a ‘cold’ sterilisation process for heat sensitive pharmaceuticals such as monoclonal antibodies, enzymes and peptides in addition to certain product containers

109
Q

Applications of radioactive sterilisation

A

Gamma-radiation has found widest use in the sterilisation of medical devices such as prosthetics, catheters, disposable plastic syringes and surgical clothing

It has also been used as a ‘cold’ sterilisation process for heat sensitive pharmaceuticals such as monoclonal antibodies, enzymes and peptides in addition to certain product containers

110
Q

Gaseous Sterilisation

A

A number of chemicals have been used as gaseous sterilants
Ethylene oxide- carcinogen, explosive – used in industry
Formaldehyde
Peracetic acid- use in hospitals- not as toxic
Hydrogen peroxide- use in hospitals- not as toxic

Vast majority of gaseous sterilisation operations are performed with ethylene oxide

111
Q

Sterilisation with ethylene oxide

A

Ethylene oxide is a colourless, practically odourless cyclic ether with a boiling point of 10.7°C at atmospheric pressure

In its pure form ethylene oxide is explosive and highly flammable with air

To reduce the risk of explosion the ethylene oxide is commonly mixed with an inert gas such as carbon dioxide or dichlorodifluoromethane

112
Q

ethylene oxide mechanism of action

A

Ethylene oxide chemically alkylates a range of chemical functional groups present within the microorganisms

Will react with other biological structures

113
Q

Sterilisation Cycles

A

A number of parameters impact upon effectiveness of sterilisation cycle
Gas concentration (500 – 800 mg/L)
Process temperature (40 - 60°C, typically 55 - 60°C)
RH ( 40 – 80%, most important parameter)

Process times of between 3 - 36hrs are typical

114
Q

applications of ethylene oxide sterilisation

A

Mainly used to sterilise wound dressing, prosthesis and intravenous sets

Incapable of sterilising aqueous solutions or gas impermeable products

Ethylene oxide is less reliable than other sterilisation methods and should only be used when other methods are not available or applicable

115
Q

filtration sterilisation

A

The technique of filtration can be defined as the separation of an insoluble solid from a liquid or gas by means of a porous medium (the filter) that retains the solid but allows the passage of liquid or gas
When the insoluble material is a microorganism suspended either in a liquid or gas then removal of the microorganisms by filtration results in a sterile liquid or gas

The mechanism by which filtration mediates sterilisation is fundamentally different to the other methods of sterilisation

Sterilisation by filtration is not by definition a terminal process since the resulting sterile solution obtained must be filled and sealed into its final container without the re-introduction of microorganisms

Therefore if contamination is to be prevented further processing of the sterile filtrate must be carefully performed under aseptic conditions
Aseptic processing requires greater manipulations and is more sensitive to the environmental conditions (microbial bioburden of the facility and product) and dependent on the capabilities of the operators
Always choose a terminal sterilisation method if at all possible

116
Q

filter composition

A

Modern filters are made of polymers
Cellulose esters (acetate and nitrate)
PTFE
Nylon
Polysulfone- low binding capacity

Polymer selection depends upon process conditions e.g. pH, presence of organic solvents, salts

117
Q

filter operation

A

Retention
Capture particles that are too large to fit through the membrane apertures (holes or channels)
Inertial impaction
Particle momentum leads to it embedding/lodging into membrane crevices and dead-ends
Adsorptive sequestration
Ionic or hydrophobic interactions between particles and membrane polymer
Chemistry and process conditions dependent (e.g. pH, salts, solvents)

118
Q

Sterilising grade filters have a nominal pore size of 0.2mm

A

Still allow the passage of certain types of microorganism or metabolites/macromolecules through
Viruses (20 - 300nm)
Mycoplasma (200 - 300nm)
Endotoxin (~ 10-10m)
Due to absolute pore size distribution the BP qualifies filter performance in terms of microbial retention

Filters will eventually fail if enough microbes are present
Mycoplasma- have no cell wall and so can squeeze through small pores in the filter

119
Q

membrane microbial retention

A

The BP states that a sterilising filter must retain a challenge of 107 CFU of Brevundimonas diminuta per cm2 of filter

No reference is made to the test conditions under which the filter is challenged

So you must qualify every membrane with your product before using to filter sterilise product

120
Q

applications of filtration sterilisation

A

Filtration is primarily used to sterilise solutions that cannot withstand heat treatment

It is also used to sterilise gases used in other processes e.g. dry heat sterilisation using hot air

Commonly used to filter solutions that are undergoing terminal sterilisation to enhance the microbial quality assurance further

121
Q

would a superficial head injury or a deeper head injury bleed more

A

superficial will bleed much, much more

122
Q

head injuries

A
  • did it bleed a lot- superficial
  • concuss( any vision problem, loss of consciousness or change in behaviour)
  • head injuries should really be checked out
  • if a child with regular injuries-safeguarding issue
  • check any medical condidition/ medications
123
Q

burn injuries

A
  • 3rd degree burns- hospital
  • any medical conditions/ medication
  • cool water- not freezing cold as this can cause shock
  • use a moist dressing like paraffin gauze (if dressing is too dry it will rip skin off when healed)
124
Q

blister injury

A
  • use a blister plaster like compeed
  • any medical conditions/ medications
    -if diabetic any foot injury should get it check regularly
124
Q

blister injury

A
  • use a blister plaster like compeed
  • any medical conditions/ medications
    -if diabetic any foot injury should be checked regularly
125
Q

big graze injury

A
  • hydrocolloid dressing - this will get any dirt or gravel to the surface, may look like puss underneath, this is normal just the dressing
  • should leave on for as long as possible
126
Q

chemical sterilisation indicators

A

autoclave tape (develops black stripes)
Browne’s tube (red to green)
thermalog strip (yellow to black)

problem with these- only rely on one sterilisation parameter (heat)